ArticleEuropean heart journal. Digital health2026
Transportability of an artificial intelligence electrocardiography model for structural heart disease: external validation and recalibration of EchoNext-Mini in MIMIC-IV.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Structural heart disease is often underdiagnosed, and echocardiography is limited by access and referral thresholds. Artificial intelligence electrocardiography (AI-ECG) may identify echocardiographically defined structural heart disease. EchoNext-Mini is a released AI-ECG model, accompanied by a benchmark dataset, that detects a composite structural heart disease outcome and component conditions from 12-lead electrocardiogram waveforms together with age, sex, and electrocardiographic measurements. We assessed its transportability and recalibration. Methods and results: We linked electrocardiograms from MIMIC-IV to subsequent transthoracic echocardiograms, including adults whose electrocardiogram preceded an eligible echocardiogram within one year, one per patient. Labels were mapped to structured echocardiographic fields using original thresholds where available, harmonized definitions otherwise. The released model was applied without retraining to this cohort and its benchmark test set, then assessed for discrimination, calibration, recalibration, subgroups, and label sensitivity. Among 45 878 patients, structural heart disease prevalence was 47.2%. Composite area under the receiver operating characteristic curve was 0.790 (95% confidence interval, 0.786 to 0.794), against 0.820 on the benchmark test set. Component values ranged from 0.679 for left ventricular wall thickness to 0.837 for right ventricular dysfunction. The composite was near-calibrated (slope, 0.93), whereas all component probabilities overestimated risk in both settings. A shift derived from the released training prevalences, requiring no local outcome data, largely corrected it. Conclusion: EchoNext-Mini transported to MIMIC-IV with composite discrimination within the published external-validation range. Component probabilities behaved as ranking scores rather than absolute risks, a property of the released model rather than the validation setting, and require adjustment before use as risk estimates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.